Publications
Detailed Information
Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kyeong-sook | - |
dc.contributor.author | Lee, You-soub | - |
dc.contributor.author | Lee, Jong-min | - |
dc.contributor.author | Ito, Kosei | - |
dc.contributor.author | Cinghu, Senthilkumar | - |
dc.contributor.author | Kim, Jang-hyun | - |
dc.contributor.author | Jang, Ju-won | - |
dc.contributor.author | Li, Yinghui | - |
dc.contributor.author | Goh, Yun-mi | - |
dc.contributor.author | Chi, Xin-zi | - |
dc.contributor.author | Wee, Heejun | - |
dc.contributor.author | Lee, Hang Woong | - |
dc.contributor.author | Hosoya, Akihiro | - |
dc.contributor.author | Chung, Jin-haeng | - |
dc.contributor.author | Jang, Ja-june | - |
dc.contributor.author | Kundu, Joydeb Kumar | - |
dc.contributor.author | Surh, Young Joon | - |
dc.contributor.author | Kim, Wun-jae | - |
dc.contributor.author | Ito, Yoshiaki | - |
dc.contributor.author | Jung, Han-sung | - |
dc.contributor.author | Bae, Sukchul | - |
dc.date.accessioned | 2012-05-31T06:19:36Z | - |
dc.date.available | 2012-05-31T06:19:36Z | - |
dc.date.created | 2017-11-15 | - |
dc.date.issued | 2010-06 | - |
dc.identifier.citation | Oncogene, Vol.29 No.23, pp.3349-3361 | - |
dc.identifier.issn | 0950-9232 | - |
dc.identifier.other | 2594 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76686 | - |
dc.description.abstract | Human lung adenocarcinoma, the most prevalent form of lung cancer, is characterized by many molecular abnormalities. K-ras mutations are associated with the initiation of lung adenocarcinomas, but K-ras-independent mechanisms may also initiate lung tumors. Here, we find that the runt-related transcription factor Runx3 is essential for normal murine lung development and is a tumor suppressor that prevents lung adenocarcinoma. Runx3-/- mice, which die soon after birth, exhibit alveolar hyperplasia. Importantly, Runx3-/- bronchioli exhibit impaired differentiation, as evidenced by the accumulation of epithelial cells containing specific markers for both alveolar (that is SP-B) and bronchiolar (that is CC10) lineages. Runx3-/- epithelial cells also express Bmi1, which supports self-renewal of stem cells. Lung adenomas spontaneously develop in aging Runx3+/- mice (similar to 18 months after birth) and invariably exhibit reduced levels of Runx3. As K-ras mutations are very rare in these adenomas, Runx3+/- mice provide an animal model for lung tumorigenesis that recapitulates the preneoplastic stage of human lung adenocarcinoma development, which is independent of K-Ras mutation. We conclude that Runx3 is essential for lung epithelial cell differentiation, and that downregulation of Runx3 is causally linked to the preneoplastic stage of lung adenocarcinoma. Oncogene (2010) 29, 3349-3361; doi:10.1038/onc.2010.79; published online 15 March 2010 | - |
dc.language | 영어 | - |
dc.language.iso | en | ko_KR |
dc.publisher | Nature Publishing Group | - |
dc.title | Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer | - |
dc.type | Article | - |
dc.contributor.AlternativeAuthor | 서영준 | - |
dc.identifier.doi | 10.1038/onc.2010.79 | - |
dc.citation.journaltitle | Oncogene | - |
dc.description.citedreference | Chi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057 | - |
dc.description.citedreference | Ito K, 2009, ONCOGENE, V28, P1379, DOI 10.1038/onc.2008.496 | - |
dc.description.citedreference | Ito T, 2008, ASIAN ECON POLICY R, V3, P237, DOI 10.1111/j.1748-3131.2008.00107.x | - |
dc.description.citedreference | Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105 | - |
dc.description.citedreference | Peacock CD, 2008, J CLIN ONCOL, V26, P2883, DOI 10.1200/JCO.2007.15.2702 | - |
dc.description.citedreference | Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017 | - |
dc.description.citedreference | Collins LG, 2007, AM FAM PHYSICIAN, V75, P56 | - |
dc.description.citedreference | Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834 | - |
dc.description.citedreference | Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369 | - |
dc.description.citedreference | Yano T, 2006, MOL CELL BIOL, V26, P4474, DOI 10.1128/MCB.01926-05 | - |
dc.description.citedreference | Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310 | - |
dc.description.citedreference | Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103 | - |
dc.description.citedreference | Sato K, 2006, ONCOL REP, V15, P129 | - |
dc.description.citedreference | Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647 | - |
dc.description.citedreference | Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743 | - |
dc.description.citedreference | Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005 | - |
dc.description.citedreference | Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032 | - |
dc.description.citedreference | Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472 | - |
dc.description.citedreference | Tozawa T, 2004, CANCER SCI, V95, P736 | - |
dc.description.citedreference | Valk-Lingbeek ME, 2004, CELL, V118, P409 | - |
dc.description.citedreference | Tuveson DA, 2004, CANCER CELL, V5, P375 | - |
dc.description.citedreference | Reddy R, 2004, AM J PHYSIOL-LUNG C, V286, pL658, DOI 10.1152/ajplung.00159.2003 | - |
dc.description.citedreference | Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385 | - |
dc.description.citedreference | Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085 | - |
dc.description.citedreference | Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503 | - |
dc.description.citedreference | Bishop AE, 2004, CELL PROLIFERAT, V37, P89 | - |
dc.description.citedreference | Xiao WH, 2004, WORLD J GASTROENTERO, V10, P376 | - |
dc.description.citedreference | Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079 | - |
dc.description.citedreference | Kato N, 2003, AM J PATHOL, V163, P387 | - |
dc.description.citedreference | Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731 | - |
dc.description.citedreference | Guo WH, 2002, ONCOGENE, V21, P8351, DOI 10.1038/sj.onc.1206037 | - |
dc.description.citedreference | Taniuchi I, 2002, MOL CELL, V10, P1083 | - |
dc.description.citedreference | Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925 | - |
dc.description.citedreference | Dimri GP, 2002, CANCER RES, V62, P4736 | - |
dc.description.citedreference | Levanon D, 2002, EMBO J, V21, P3454 | - |
dc.description.citedreference | Li QL, 2002, CELL, V109, P113 | - |
dc.description.citedreference | Lund AH, 2002, CANCER CELL, V1, P213 | - |
dc.description.citedreference | Minna JD, 2002, CANCER CELL, V1, P49 | - |
dc.description.citedreference | Jackson EL, 2001, GENE DEV, V15, P3243 | - |
dc.description.citedreference | Bangsow C, 2001, GENE, V279, P221 | - |
dc.description.citedreference | Osanai M, 2001, ULTRASTRUCT PATHOL, V25, P367 | - |
dc.description.citedreference | Vonlanthen S, 2001, BRIT J CANCER, V84, P1372 | - |
dc.description.citedreference | Bea S, 2001, CANCER RES, V61, P2409 | - |
dc.description.citedreference | Petersen I, 2001, ANAL CELL PATHOL, V22, P111 | - |
dc.description.citedreference | COSTA RH, 2001, AM J PHYSIOL-LUNG C, V280, P823 | - |
dc.description.citedreference | ZOCHBAUERMULLER S, 2000, CHEST SURG CLIN N AM, V10, P691 | - |
dc.description.citedreference | Mori M, 1998, ULTRASTRUCT PATHOL, V22, P459 | - |
dc.description.citedreference | Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891 | - |
dc.description.citedreference | Malkinson AM, 1998, EXP LUNG RES, V24, P541 | - |
dc.description.citedreference | Cazorla M, 1998, MOL CARCINOGEN, V21, P251 | - |
dc.description.citedreference | Look AT, 1997, SCIENCE, V278, P1059 | - |
dc.description.citedreference | Lee B, 1997, NAT GENET, V16, P307 | - |
dc.description.citedreference | Otto F, 1997, CELL, V89, P765 | - |
dc.description.citedreference | Mundlos S, 1997, FASEB J, V11, P125 | - |
dc.description.citedreference | Westra WH, 1996, CANCER RES, V56, P2224 | - |
dc.description.citedreference | Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113 | - |
dc.description.citedreference | OKUDA T, 1996, MOL DIAGN, V1, P139 | - |
dc.description.tc | 10 | - |
dc.identifier.wosid | 000278622700004 | - |
dc.identifier.scopusid | 2-s2.0-77953480629 | - |
dc.citation.endpage | 3361 | - |
dc.citation.number | 23 | - |
dc.citation.startpage | 3349 | - |
dc.citation.volume | 29 | - |
dc.identifier.sci | 000278622700004 | - |
dc.description.isOpenAccess | N | - |
dc.contributor.affiliatedAuthor | Chung, Jin-haeng | - |
dc.contributor.affiliatedAuthor | Jang, Ja-june | - |
dc.contributor.affiliatedAuthor | Surh, Young Joon | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | ATYPICAL ADENOMATOUS HYPERPLASIA | - |
dc.subject.keywordPlus | TUMOR-SUPPRESSOR | - |
dc.subject.keywordPlus | GASTRIC-CANCER | - |
dc.subject.keywordPlus | STEM-CELLS | - |
dc.subject.keywordPlus | PROMOTER HYPERMETHYLATION | - |
dc.subject.keywordPlus | CLEIDOCRANIAL DYSPLASIA | - |
dc.subject.keywordPlus | PROTEIN MISLOCALIZATION | - |
dc.subject.keywordPlus | EPIGENETIC INACTIVATION | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTORS | - |
dc.subject.keywordPlus | K-RAS | - |
dc.subject.keywordAuthor | RUNX3 | - |
dc.subject.keywordAuthor | lung | - |
dc.subject.keywordAuthor | adenocarcinoma | - |
dc.subject.keywordAuthor | adenoma | - |
dc.subject.keywordAuthor | tumor suppressor | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.